These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12365285)

  • 21. Current progress in tissue engineering of heart valves: multiscale problems, multiscale solutions.
    Cheung DY; Duan B; Butcher JT
    Expert Opin Biol Ther; 2015; 15(8):1155-72. PubMed ID: 26027436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Tissue engineering of heart valves: new opportunities and challenges].
    Bobylev DO; Chebotar' S; Tudorake I; Khaverikh A
    Kardiologiia; 2011; 51(12):50-6. PubMed ID: 22304317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioengineered living cardiac and venous valve replacements: current status and future prospects.
    Kehl D; Weber B; Hoerstrup SP
    Cardiovasc Pathol; 2016; 25(4):300-305. PubMed ID: 27167776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tissue engineering of blood vessels in cardiovascular disease: moving towards clinical translation.
    Udelsman BV; Maxfield MW; Breuer CK
    Heart; 2013 Apr; 99(7):454-60. PubMed ID: 23363931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cells for tissue engineering of cardiac valves.
    Jana S; Tranquillo RT; Lerman A
    J Tissue Eng Regen Med; 2016 Oct; 10(10):804-824. PubMed ID: 25712485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends in cardiovascular engineering: organizing the human heart.
    Tulloch NL; Murry CE
    Trends Cardiovasc Med; 2013 Nov; 23(8):282-6. PubMed ID: 23722092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cells, scaffolds, and molecules for myocardial tissue engineering.
    Leor J; Amsalem Y; Cohen S
    Pharmacol Ther; 2005 Feb; 105(2):151-63. PubMed ID: 15670624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heart valve and arterial tissue engineering.
    Sarraf CE; Harris AB; McCulloch AD; Eastwood M
    Cell Prolif; 2003 Oct; 36(5):241-54. PubMed ID: 14521518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human or animal homograft: could they have a future as a biological scaffold for engineered heart valves?
    Dainese L; Biglioli P
    J Cardiovasc Surg (Torino); 2010 Jun; 51(3):449-56. PubMed ID: 20523298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heart valve tissue engineering.
    Neuenschwander S; Hoerstrup SP
    Transpl Immunol; 2004 Apr; 12(3-4):359-65. PubMed ID: 15157927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of stem cells for cardiovascular grafts tissue engineering.
    Wu K; Liu YL; Cui B; Han Z
    Transpl Immunol; 2006 Jun; 16(1):1-7. PubMed ID: 16701169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative study of cellular and extracellular matrix composition of native and tissue engineered heart valves.
    Schenke-Layland K; Riemann I; Opitz F; König K; Halbhuber KJ; Stock UA
    Matrix Biol; 2004 May; 23(2):113-25. PubMed ID: 15246110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue engineering of heart valves: decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells.
    Rieder E; Seebacher G; Kasimir MT; Eichmair E; Winter B; Dekan B; Wolner E; Simon P; Weigel G
    Circulation; 2005 May; 111(21):2792-7. PubMed ID: 15911701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stem cells: new cell source for myocardial constructs tissue engineering.
    Wu KH; Cui B; Yu CT; Liu YL
    Med Hypotheses; 2006; 67(6):1326-9. PubMed ID: 16814940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac tissue engineering: current state and perspectives.
    Chiu LL; Iyer RK; Reis LA; Nunes SS; Radisic M
    Front Biosci (Landmark Ed); 2012 Jan; 17(4):1533-50. PubMed ID: 22201819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tissue engineering of heart valves: decellularized valve scaffolds.
    Hopkins RA
    Circulation; 2005 May; 111(21):2712-4. PubMed ID: 15927986
    [No Abstract]   [Full Text] [Related]  

  • 37. Heart valve tissue engineering: concepts, approaches, progress, and challenges.
    Mendelson K; Schoen FJ
    Ann Biomed Eng; 2006 Dec; 34(12):1799-819. PubMed ID: 17053986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanofiber-reinforced myocardial tissue-construct as ventricular assist device.
    Guhathakurta S; Mathapati S; Bishi DK; Rallapalli S; Cherian KM
    Asian Cardiovasc Thorac Ann; 2014 Oct; 22(8):935-43. PubMed ID: 24585303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro engineering of heart muscle: artificial myocardial tissue.
    Kofidis T; Akhyari P; Boublik J; Theodorou P; Martin U; Ruhparwar A; Fischer S; Eschenhagen T; Kubis HP; Kraft T; Leyh R; Haverich A
    J Thorac Cardiovasc Surg; 2002 Jul; 124(1):63-9. PubMed ID: 12091810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cryopreserved amniotic fluid-derived cells: a lifelong autologous fetal stem cell source for heart valve tissue engineering.
    Schmidt D; Achermann J; Odermatt B; Genoni M; Zund G; Hoerstrup SP
    J Heart Valve Dis; 2008 Jul; 17(4):446-55; discussion 455. PubMed ID: 18751475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.